References

Exploring carbohydrates for therapeutics: a review on future directions

2021 · External reference

U.S. FDA approved drugs from 2015−June 2020: a perspective

10.1021/acs.jmedchem.0c01786 · 2021 · External reference

Glycomimetics and glycoconjugates in drug discovery

10.3390/ph17030323 · 2024 · External reference

Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases

10.1039/c6cc01564f · 2016 · External reference

N-Alkylated iminosugar based ligands: synthesis and inhibition of human lysosomal β-glucocerebrosidase

10.3390/molecules25204618 · 2020 · External reference

sp2-Iminosugar azobenzene O-glycosides: Light-sensitive glycosidase inhibitors with unprecedented tunability and switching factors

10.1016/j.bioorg.2024.107555 · 2024 · External reference

sp2-Iminosugars as chemical mimics for glycodrug design

2020 · External reference

Exploring a novel anti-inflammatory therapy for diabetic retinopathy based on glyco-zeolitic-imidazolate frameworks

10.3390/pharmaceutics17060791 · 2025 · External reference

Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives

10.2174/092986708783503221 · 2008 · External reference

The antileishmanial drug miltefosine (Impavido®) causes oxidation of DNA bases, apoptosis, and necrosis in mammalian cells

10.1016/j.mrgentox.2016.06.007 · 2016 · External reference

Dysfunctional adaptive immunity during parasitic infections

10.2174/1573395509666131126230832 · 2013 · External reference

Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties

10.1016/j.ejmech.2023.115390 · 2023 · External reference

Exploring the influence of the glycone space on the therapeutic potential of sp2-iminoglycolipids

10.1016/j.ejmech.2025.118337 · 2026 · External reference

sp2-Iminosugar glycolipids as inhibitors of lipopolysaccharide mediated human dendritic cell activation in vitro and of acute inflammation in mice in vivo

10.1016/j.ejmech.2019.02.078 · 2019 · External reference

Function and inhibition of P38 MAP kinase signaling: targeting multiple inflammation diseases

10.1016/j.bcp.2023.115973 · 2024 · External reference

Diversity and versatility of p38 kinase signalling in health and disease

10.1038/s41580-020-00322-w · 2021 · External reference

Recent insights in multi-target drugs in pharmacology and medicinal chemistry

2025 · External reference

Toward dual-target glycomimetics against two bacterial lectins to fight Pseudomonas aeruginosa−burkholderia cenocepacia infections: a biophysical study

10.1021/acs.jmedchem.5c00405 · 2025 · External reference

Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes

10.1016/j.bioorg.2019.03.053 · 2019 · External reference

An orally available halothiazole glycomimetic as a cancer-targeting dual Galectin-1 and Galectin-3 inhibitor

10.1021/acs.jmedchem.5c03703 · 2026 · External reference

Selenoureido-N-alkyl-3,4,5-trihydroxypiperidines: probing their dual-target role in Gaucher disease

10.1016/j.bmc.2025.118453 · 2026 · External reference

Evidence of α-synuclein/glucocerebrosidase dual targeting by iminosugar derivatives

10.1021/acschemneuro.4c00618 · 2025 · External reference

Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases

10.1039/b712690p · 2008 · External reference

Recent advances in chemical synthesis of amino sugars

10.3390/molecules28124724 · 2023 · External reference

Synthesis of antimitotic thioglycosides: in vitro and in vivo evaluation of their anticancer activity

10.1021/jm200961q · 2011 · External reference

Synthesis, biological evaluation, and computational studies of phenolic N-acetylglucosamine glycosides as α-glucosidase inhibitors

10.3390/md24020084 · 2026 · External reference

Tn Antigen mimics based on sp2-iminosugars with affinity for an anti-MUC1 antibody

10.1021/acs.orglett.6b01899 · 2016 · External reference

Über die Verseifung acetylierter Zucker und verwandter Substanzen

10.1002/cber.19290620640 · 1929 · External reference

Staudinger ligation and reactions – from bioorthogonal labeling to next-generation biopharmaceuticals

10.1002/ijch.202200057 · 2023 · External reference

Malaria and leishmaniasis: updates on co-infection

10.3389/fimmu.2023.1122411 · 2023 · External reference

Leishmaniasis vaccine development: a review of current candidates and cross-species protection potential

10.3390/parasitologia6020016 · 2026 · External reference

A review of leishmaniasis: current knowledge and future directions

10.1007/s40475-021-00232-7 · 2021 · External reference

Increased ROS generation causes apoptosis-like death: mechanistic insights into the anti-leishmania activity of a potent ruthenium(II) complex

10.1016/j.jinorgbio.2019.03.005 · 2019 · External reference

Diabetic retinopathy (DR): mechanisms, current therapies, and emerging strategies

10.3390/cells14050376 · 2025 · External reference

Which treatment modality offers the best outcomes for diabetic retinopathy? A systematic review and network meta-analysis

10.1016/j.diabres.2025.112379 · 2025 · External reference

Lipopolysaccharide induces inflammatory microglial activation through CD147-mediated matrix metalloproteinase expression

2023 · External reference

Dexamethasone in COVID-19 treatment: analyzing monotherapy and combination therapy approaches

2024 · External reference

Role of inflammasomes in neuroimmune and neurodegenerative diseases: a systematic review

10.1155/2018/1549549 · 2018 · External reference

Activation and regulation of the inflammasomes

10.1038/nri3452 · 2013 · External reference

Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group

2000 · External reference

Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats

10.1167/iovs.11-9241 · 2012 · External reference

LPS induction of gene expression in human monocytes

10.1016/s0898-6568(00)00149-2 · 2001 · External reference

Anti-inflammatory (M2) response is induced by a sp2-iminosugar glycolipid sulfoxide in diabetic retinopathy

10.3389/fimmu.2021.632132 · 2021 · External reference

Arylphthalide delays diabetic retinopathy via immunomodulating the early inflammatory response in an animal model of type 1 diabetes mellitus

10.3390/ijms25158440 · 2024 · External reference

Fitness of Leishmania donovani parasites resistant to drug combinations

10.1371/journal.pntd.0003704 · 2015 · External reference

Heme synthesis through the life cycle of the heme auxotrophic parasite Leishmania major

10.1096/fj.201901274rr · 2019 · External reference

A yeast-based high-throughput screen identifies inhibitors of trypanosomatid HRG heme transporters with potent leishmanicidal and trypanocidal activity

10.1016/j.ijantimicag.2024.107092 · 2024 · External reference

Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis

10.1371/journal.ppat.1013993 · 2026 · External reference